17

Introduction: Cutaneous manifestations of HAT are common and often go unrecognized by healthcare providers. The objective of this research was to describe the epidemiological, therapeutic, and progressive aspects of the cutaneous manifestations of HAT. Patients and methods: This is an ambispective, descriptive, and analytical study of HAT patients presentingcutaneous manifestations, treated and monitored at the center from 01/01/2018 to 12/31/2023. The variables analyzed were epidemiological, clinical, paraclinical, therapeutic, and progressive. Results: The prevalence of cutaneous signs was 67.9%, and the most represented data were: the age group ≥ 20 years (74.4%) with a sex ratio of 1.31; activities with lower risk of HAT (58.4%), passive patients (55.2%); patients in phase II (99.2%), pruritus (100%) of severe intensity (50%), scratching lesions (78.4%) localized on the thorax (82.6%), upper (75 .5%) and lower (54.1%) limbs, and abdomen (50.9%); therapeutic abstinence (82.4%), and the association of other dermatological diseases (23.2%). The average evolution of skin signs was six months, and on average after two months 96.7% of the patients monitored were completely cured. The factors significantly associated with scratching lesions in multivariate analysis were thoracic location (p: 0.0006), age group from 0 to 19 years (p: 0.03), activities with a higher risk of HAT (p: 0.03), and leukorachia ≥100cel/μl (p: 0.01). Conclusion: Scraping lesions on the thorax are highly indicative of HAT.